Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,979 | 11,328 | 8,684 | 5,969 | 3,345 |
| Depreciation Amortization | 700 | 2,240 | 1,633 | 1,085 | 545 |
| Income taxes - deferred | N/A | 1,550 | 298 | 218 | 98 |
| Accounts receivable | -6,956 | -844 | -871 | -853 | -1,118 |
| Other Working Capital | -5,587 | -2,088 | -1,343 | -1,038 | -702 |
| Other Operating Activity | 6,988 | 972 | 972 | 920 | 1,151 |
| Operating Cash Flow | $-876 | $13,158 | $9,372 | $6,301 | $3,319 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,969 | -10,367 | 43,579 | -4,814 | 913 |
| Purchase Of Investment | N/A | N/A | -50,934 | N/A | N/A |
| Investing Cash Flow | $5,969 | $-10,367 | $-7,355 | $-4,814 | $913 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 132 | 396 | 258 | 258 | 258 |
| Common Stock Repurchased | N/A | -617 | -617 | -479 | -222 |
| Financing Cash Flow | $132 | $-221 | $-358 | $-221 | $36 |
| Beginning Cash Position | 7,334 | 4,763 | 4,763 | 4,763 | 4,763 |
| End Cash Position | 12,559 | 7,334 | 6,422 | 6,030 | 9,032 |
| Net Cash Flow | $5,225 | $2,570 | $1,659 | $1,267 | $4,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -876 | 13,158 | 9,372 | 6,301 | 3,319 |
| Free Cash Flow | -876 | 13,158 | 9,372 | 6,301 | 3,319 |